Close menu


Updated: 2017-08-21T18:33Z
Breast fibradenoma (1).jpg
Histopathologic image of breast fibroadenoma. Core needle biopsy. Hematoxylin & eosin stain.
Classification and external resources
ICD-OM9010/0-M9012, M9020, M9030
Patient UKFibroadenoma
[[[d:Lua error in Module:Wikidata at line 1016: attempt to index field 'wikibase' (a nil value).|edit on Wikidata]]]

Fibroadenomas of the breast are benign tumors characterized by an admixture of stromal and epithelial tissue. Breasts are made of lobules (milk producing glands) and ducts (tubes that carry the milk to the nipple). These are surrounded by glandular, fibrous and fatty tissues. Fibroadenomas develop from the lobules. The glandular tissue and ducts grow over the lobule to form a solid lump.

Since both fibroadenomas and breast cancer can appear as similar lumps, it is currently recommended to perform ultrasound analyses and possibly tissue sampling with subsequent histopathologic analysis in order to perform diagnosis. Unlike typical lumps from breast cancer, fibroadenomas are easy to move, with clearly defined edges.[1][2]

Fibroadenomas are sometimes called breast mice or a breast mouse owing to their high mobility in the breast.[3]

Signs and symptoms

The typical case is the presence of a painless, firm, solitary, mobile, slowly growing lump in the breast of a woman of child-bearing years.[2][4][5]

In the male breast, fibroepithelial tumors are very rare, and are mostly phyllodes tumors. Exceptionally rare case reports exist of fibroadenomas in the male breast, however these cases may be associated with antiandrogen treatment.[6]


Fibroadenomas are partially hormone-related and frequently regress after menopause.

Higher intake of fruits and vegetables, higher number of live births, lower use of oral contraceptives and moderate exercise are associated with lower frequency of fibroadenomas.[7]


Macroscopic view of fibroadenoma of the breast
Closeup of a fibroadenoma of the breast


The diagnostic findings on needle biopsy consist of abundant stromal cells, which appear as bare bipolar nuclei, throughout the aspirate; sheets of fairly uniform-size epithelial cells that are typically arranged in either an antler-like pattern or a honeycomb pattern. These epithelial sheets tend to show typical metachromatic blue staining on DiffQuick staining. Foam cells and apocrine cells may also be seen, although these are less diagnostic features.[4][8] The gallery images below demonstrate these features.

Cellular fibroadenoma, also known as juvenile fibroadenoma, is a variant type of fibroadenoma with increased stromal cellularity.[9][10]


Approximately 90% of fibroadenomas are less than 3 cm in diameter. However, these tumors have the potential to grow reaching a remarkable size, particularly in young individuals. The tumor is round or ovoid, elastic, and nodular, and has a smooth surface. The cut surface usually appears homogenous and firm, and is grey-white or tan in colour.The pericanalicular type (hard) has a whorly appearance with a complete capsule, while the intracanalicular type (soft) has an incomplete capsule.[8]


Fibroadenoma of the breast is a benign tumor composed of a biphasic proliferation of both stromal and epithelial components that can be arranged in two growth patterns: pericanalicular (stromal proliferation around epithelial structures) and intracanalicular (stromal proliferation compressing the epithelial structures into clefts).

These tumors characteristically display hypovascular stroma compared to malignant neoplasms.[2][5][8] Furthermore, the epithelial proliferation appears in a single terminal ductal unit and describes duct-like spaces surrounded by a fibroblastic stroma. The basement membrane is intact.[11]

Molecular pathology

Up to 66% of fibroadenomas harbor somatic mutations in the exon 2 of the mediator complex subunit 12 (MED12) gene. In particular, these mutations are restricted to the stromal component.[12][13]


A fibroadenoma is usually diagnosed through clinical examination, ultrasound or mammography, and often a needle biopsy sample of the lump.[4]


Most fibroadenomas are left in situ and monitored by a doctor, or the patient in question. Some are treated by surgical excision. They are removed with a small margin of normal breast tissue if the preoperative clinical investigations are suggestive of the necessity of this procedure. A small amount of normal tissue must be removed in case the lesion turns out to be a phyllodes tumour on microscopic examination.[8][14]

Because needle biopsy is often a reliable diagnostic investigation, some doctors may decide not to operate to remove the lesion, and instead opt for clinical follow-up to observe the lesion over time using clinical examination and mammography to determine the rate of growth, if any, of the lesion. A growth rate of less than sixteen percent per month in women under fifty years of age, and a growth rate of less than thirteen percent per month in women over fifty years of age have been published as safe growth rates for continued non-operative treatment and clinical observation.[15]

Some fibroadenomas respond to treatment with ormeloxifene.[16]

Fibroadenomas have not been shown to recur following complete excision or transform into phyllodes tumours following partial or incomplete excision.[8]

There are also natural treatments being touted to diminish fibroadenomas, such as Fibrosolve, but no definite studies have been made as to prove their effectiveness.


The FDA has approved cryoablation of a fibroadenoma as a safe, effective and minimally-invasive alternative to open surgical removal in 2001.[17] In the procedure, ultrasound imaging is used to guide a probe into the mass of breast tissue. Extremely cold temperatures are then used to destroy the abnormal cells,[18] and over time the cells are reabsorbed into the body. The procedure can be performed in an office setting with local anesthesia only, and leaves substantially less scarring than open surgical procedures and no breast tissue deformation.[18]

The American Society of Breast Surgeons recommends the following criteria to establish a patient as a candidate for cryoablation of a fibroadenoma:[17]

  1. The lesion must be sonographically visible.
  2. The diagnosis of fibroadenoma must be confirmed histologically.
  3. Lesions should be less than 4 cm in diameter.


An alternative using high intensity focused ultrasound or HIFU has recently proved its efficacy in treating fibroadenoma. This method is noninvasive, without general anesthesia and is performed in an ambulatory setting. Ultrasound waves are focused and produce heat enabling to destroy fibroadenomas.This method is non-invasive and relies on tissue heating to destroy fibroadenoma cells.[19]

Focused ultrasounds have been used to treat other benign tumors, such as fibroid disease in the uterus.[20]


They are the most common breast tumor in adolescent women. They also occur in a small number of post-menopausal women. Their incidence declines with increasing age, and, in general, they appear before the age of thirty years.[citation needed]


  1. ^ 22-251c.Fibroadenomas at Merck Manual of Diagnosis and Therapy Home Edition
  2. ^ a b c Tavassoli, F.A.; Devilee, P., eds. (2003). World Health Organization Classification of Tumours: Pathology & Genetics: Tumours of the breast and female genital organs. Lyon: IARC Press. ISBN 92-832-2412-4. [page needed]
  3. ^ Dirbas, Fredrick M.; Scott-Conner, Carol E.H., eds. (2010). Breast surgery office management and surgical techniques. New York: Springer. p. 71. ISBN 978-1-4419-6075-7. 
  4. ^ a b c DeMay, M. Practical Principles of Cytopathology (Revised ed.). ASCP Press. p. 2007. ISBN 0-89189-549-3. [page needed]
  5. ^ a b Pathology Outlines Website. [1] Accessed 12 February 2009.
  6. ^ Shin SJ, Rosen PP (July 2007). "Bilateral presentation of fibroadenoma with digital fibroma-like inclusions in the male breast". Archives of Pathology & Laboratory Medicine. 131 (7): 1126–9. PMID 17617003. doi:10.1043/1543-2165(2007)131[1126:BPOFWD]2.0.CO;2 (inactive 2017-08-21). 
  7. ^ Nelson ZC, Ray RM, Wu C, Stalsberg H, Porter P, Lampe JW, Shannon J, Horner N, Li W, Wang W, Hu Y, Gao D, Thomas DB (July 2010). "Fruit and vegetable intakes are associated with lower risk of breast fibroadenomas in Chinese women". The Journal of Nutrition. 140 (7): 1294–301. PMC 2884330Freely accessible. PMID 20484549. doi:10.3945/jn.109.119719. 
  8. ^ a b c d e Rosen, PP. Rosen's Breast Pathology (3rd ed.). ISBN 978-0-7817-7137-5. [page needed]
  9. ^ Fekete P, Petrek J, Majmudar B, Someren A, Sandberg W (May 1987). "Fibroadenomas with stromal cellularity. A clinicopathologic study of 21 patients". Archives of Pathology & Laboratory Medicine. 111 (5): 427–32. PMID 3032124. 
  10. ^ Nassar, Hind. "Cellular fibroadenoma of breast". Retrieved 14 January 2013. 
  11. ^ "Fibroadenoma of the breast". Retrieved 2007-12-15. 
  12. ^ Lim WK, Ong CK, Tan J, Thike AA, Ng CC, Rajasegaran V, Myint SS, Nagarajan S, Nasir ND, McPherson JR, Cutcutache I, Poore G, Tay ST, Ooi WS, Tan VK, Hartman M, Ong KW, Tan BK, Rozen SG, Tan PH, Tan P, Teh BT (August 2014). "Exome sequencing identifies highly recurrent MED12 somatic mutations in breast fibroadenoma". Nature Genetics. 46 (8): 877–80. PMID 25038752. doi:10.1038/ng.3037. 
  13. ^ Piscuoglio S, Murray M, Fusco N, Marchiò C, Loo FL, Martelotto LG, Schultheis AM, Akram M, Weigelt B, Brogi E, Reis-Filho JS (November 2015). "MED12 somatic mutations in fibroadenomas and phyllodes tumours of the breast". Histopathology. 67 (5): 719–29. PMC 4996373Freely accessible. PMID 25855048. doi:10.1111/his.12712. 
  14. ^ Rosai, J. (2004). Rosai and Ackerman's Surgical Pathology (9th ed.). ISBN 0-323-01342-2. [page needed]
  15. ^ Gordon PB, Gagnon FA, Lanzkowsky L (October 2003). "Solid breast masses diagnosed as fibroadenoma at fine-needle aspiration biopsy: acceptable rates of growth at long-term follow-up". Radiology. 229 (1): 233–8. PMID 14519878. doi:10.1148/radiol.2291010282. 
  16. ^ Dhar A, Srivastava A (June 2007). "Role of centchroman in regression of mastalgia and fibroadenoma". World Journal of Surgery. 31 (6): 1178–84. PMID 17431715. doi:10.1007/s00268-007-9040-4. 
  17. ^ a b Management of Fibroadenomas of the Breast
  18. ^ a b WebMD — Cryotherapy Shrinks Benign Breast Lumps
  19. ^ "Echotherapy: Fibroadenomas". 
  20. ^ Jolesz FA, Hynynen K, McDannold N, Tempany C (August 2005). "MR imaging-controlled focused ultrasound ablation: a noninvasive image-guided surgery". Magnetic Resonance Imaging Clinics of North America. 13 (3): 545–60. PMID 16084419. doi:10.1016/j.mric.2005.04.008. 

Further reading

  • Jolesz FA, Hynynen K, McDannold N, Tempany C (August 2005). "MR imaging-controlled focused ultrasound ablation: a noninvasive image-guided surgery". Magnetic Resonance Imaging Clinics of North America. 13 (3): 545–60. PMID 16084419. doi:10.1016/j.mric.2005.04.008. 
  • Gombos EC, Kacher DF, Furusawa H, Namba K (June 2006). "Breast focused ultrasound surgery with magnetic resonance guidance". Topics in Magnetic Resonance Imaging. 17 (3): 181–8. PMID 17414075. doi:10.1097/rmr.0b013e318033789f. 
  • Hynynen K, Pomeroy O, Smith DN, Huber PE, McDannold NJ, Kettenbach J, Baum J, Singer S, Jolesz FA (April 2001). "MR imaging-guided focused ultrasound surgery of fibroadenomas in the breast: a feasibility study". Radiology. 219 (1): 176–85. PMID 11274554. doi:10.1148/radiology.219.1.r01ap02176. 
  • Marret H, Bleuzen A, Guérin A, Lauvin-Gaillard MA, Herbreteau D, Patat F, Tranquart F (January 2011). "[French first results using magnetic resonance-guided focused ultrasound for myoma treatment]" [French first results using magnetic resonance-guided focused ultrasound for myoma treatment]. Gynecologie, Obstetrique & Fertilite (in French). 39 (1): 12–20. PMID 21185759. doi:10.1016/j.gyobfe.2010.08.038. 

External links

Text is available under the Creative Commons Attribution-ShareAlike License; additional terms may apply. By using this site, you agree to the Terms of Use and Privacy Policy. Wikipedia is a registered trademark of the Wikimedia Foundation, Inc., a non-profit organization.

Also On Wow


    Trending Now